BNR
Burning Rock Biotech Ltd
16.30$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -120.3% | -71.2% | -59.7% | -17.1% | -94.1% | -81.1% | -47.6% | -17.9% | -5.3% | |
| 19.2% | 11.8% | 8.2% | 7.7% | 9.4% | 22.0% | 24.8% | 10.1% | 4.0% | |
| 3.6% | 2.4% | 6.0% | 40.3% | 55.6% | 58.0% | 48.5% | 30.2% | 2.6% | |
| 9.9% | 4.9% | 10.5% | 43.8% | 62.8% | 71.3% | – | – | – | |
| -31.3% | -2.9% | -34.2% | 26.1% | -12.3% | -2.0% | -9.7% | -7.1% | -11.0% | |
| 20.7% | 11.8% | 12.0% | 18.5% | 42.0% | 11.0% | 1.7% | 1.2% | 1.0% | |
| -171.9% | 50.8% | -90.8% | -25.4% | 16.1% | -1.3% | -1.7% | -0.9% | -0.8% | |
| – | – | – | 83.8% | – | – | – | – | – | |
| -8.2% | -0.7% | -1.0% | -0.8% | -0.8% | -12.8% | -1.3% | 0.0% | 0.0% | |
| 115.8% | 39.7% | -21.4% | -4.8% | -8.8% | -0.4% | 0.0% | 0.0% | 0.4% | |
| 318.6% | 39.9% | 149.8% | 503.8% | -10.4% | -15.3% | -9.1% | 0.0% | 0.4% | |
| 16.2% | 19.4% | 0.8% | 425.0% | -95.7% | -91.2% | -57.7% | -18.0% | -7.6% | |
| -141.0% | -83.1% | -71.7% | -35.6% | -136.1% | -92.1% | -49.3% | -19.0% | -6.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.